Vanguard Group Inc An2 Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,035,947 shares of ANTX stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,035,947
Previous 1,035,947
-0.0%
Holding current value
$1.1 Million
Previous $1.41 Million
22.02%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ANTX
# of Institutions
38Shares Held
7.58MCall Options Held
0Put Options Held
0-
Almitas Capital LLC Santa Monica, CA1.43MShares$1.51 Million0.71% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY583KShares$617,7360.62% of portfolio
-
Stonepine Capital Management, LLC Bend, OR544KShares$577,1630.57% of portfolio
-
Landscape Capital Management, L.L.C.495KShares$525,1190.05% of portfolio
-
Bank Of Nova Scotia459KShares$486,7450.0% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $20.6M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...